XTL Biopharmaceuticals Sponsored ADR's total assets for Q3 2024 were $9.28M, an increase of 286.99% from the previous quarter. XTLB total liabilities were $3.56M for the fiscal quarter, a 2059.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Total Assets
$ 8.55M
$ 2.43M
$ 4.19M
$ 6.62M
$ 6.50M
Total Liabilities
$ 3.12M
$ 206.00K
$ 187.00K
$ 1.28M
$ 254.00K
Total Equity Gross Minority
$ 5.43M
$ 2.22M
$ 4.00M
$ 5.33M
$ 6.25M
Other Metrics
Currency in USD
XTL Biopharmaceuticals Sponsored ADR Debt to Assets